Skip to main content

Table 2 Medical and treatment characteristics

From: Adult ADHD patient experiences of impairment, service provision and clinical management in England: a qualitative study

  Diagnosed in adulthood (n = 15) N (%) Diagnosed in childhood (n = 15) N (%)
Current Medication use   
Using Medication 13 (87) 12 (80)
Discontinued Medication* 2 (13) 3 (20)
Current Medication Type   
Methylphenidate 10 (77) 11 (92)
Atomoxetine 1 (8) 1 (8)
Dexamphetamine 2 (15) 0 (0)
Duration Since Diagnosis   
< 1 year 1 (7) 0 (0)
1-5 years 4 (27) 2 (13)
6-10 years 7 (47) 4 (27)
11-15 years 2 (13) 8 (53)
16+ years 1 (7) 1 (7)
Duration on ADHD Medication** (n = 24)   
< 1 year 5 (42) 3 (25)
1-5 years 4 (33) 2 (17)
6-10 years 2 (17) 5 (42)
11-15 years 0 (0) 2 (17)
16+ years 1 (8) 0 (0)
  1. *Discontinued for a period of 6 months or longer.
  2. **missing data for 6 participants.